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Abstract
Background. Lower respiratory tract infection (LRTI) is a common presentation in primary care, 
but little is known about associated patients’ illness perception and related behaviour.
Objective. To describe illness perceptions and related behaviour in patients with LRTI visiting their 
general practitioner (GP) and identify differences between European regions and types of health 
care system.
Methods. Adult patients presenting with acute cough were included. GPs recorded co morbidities 
and clinical findings. Patients filled out a diary for up to 4 weeks on their symptoms, illness 
perception and related behaviour. The chi-square test was used to compare proportions between 
groups and the Mann-Whitney U or Kruskal Wallis tests were used to compare means.
Results. Three thousand one hundred six patients from 12 European countries were included. 
Eighty-one per cent (n = 2530) of the patients completed the diary. Patients were feeling unwell 
for a mean of 9 (SD 8)  days prior to consulting. More than half experienced impairment of 
normal or social activities for at least 1 week and were absent from work/school for a mean of 4 
(SD 5) days. On average patients felt recovered 2 weeks after visiting their GP, but 21% (n = 539) 
of the patients did not feel recovered after 4 weeks. Twenty-seven per cent (n = 691) reported 
feeling anxious or depressed, and 28% (n = 702) re-consulted their GP at some point during the 
illness episode. Reported illness duration and days absent from work/school differed between 
countries and regions (North-West versus South-East), but there was little difference in reported 
illness course and related behaviour between health care systems (direct access versus gate-
keeping).
Conclusion. Illness course, perception and related behaviour in LRTI differ considerably between 
countries. These finding should be taken into account when developing International guidelines for 
LRTI and interventions for setting realistic expectations about illness course.
Key words: Activities of daily living, bronchitis, cough, general practice, illness behaviour, respiratory tract infections, sick leave.
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Introduction
Lower respiratory tract infections (LRTIs) include bronchitis, bron-
chiolitis and pneumonia. These infections are among the main rea-
sons people seek primary health care. The annual incidence rate of 
LRTI as diagnosed by general practitioners (GPs) ranges from 28 
to 53 per 1000 persons (1,2). Concerns and interference with social 
roles are often reasons for consulting a GP. Although LRTI seldom 
leads to serious complications and is mostly self-limiting (3,4), 
patients are impaired in daily activities including work, resulting in 
a substantial burden for patients and society (3). Respiratory tract 
illnesses are the second leading cause of sick leave with an average 
of 3  days absence from work (5). Impairment in social activities, 
absence from work and health seeking behaviour during an illness 
episode are all regarded as elements of illness behaviour. Illness 
behaviour is defined as the manner in which people behave differen-
tially according to how they perceive, evaluate and respond to symp-
toms, and is a product of social and cultural conditioning. Illness 
behaviour differs by region and group for some common infections. 
De Melker et  al. (6) found differences in duration of illness prior 
to presentation to the GP, and in total illness duration between 
Eastern and Western Europe in acute tonsillitis. In addition, van der 
Linden et  al. (2) found patients with lower educational level and 
patients with a non-Western origin consult their GP more frequently. 
There have been some descriptions of illness perceptions and related 
behaviour in LRTI, but few studies have followed-up patients for 
longer than 3 weeks. In addition, the extent of variation in LRTI ill-
ness perceptions and related behaviour between regions has not been 
described (3,4). Knowledge about perceptions and related behaviour 
of illness in patients with LRTI could help to provide better patient 
information, design future studies on LRTI and contribute to the 
development of internationally applicable management guidelines.
Therefore, we aimed to describe illness perceptions and related 
behaviour in patients visiting their GP with LRTI overall, and identify 
differences between European regions and types of health care system.
Methods
Study subjects and design
This prospective observational study in primary care is part of the 
GRACE project (Genomics to combat Resistance against Antibiotics 
in Community-acquired LRTI in Europe; www.grace-lrti.org). 
Details on the study population have been reported elsewhere (7). 
GPs in 16 primary care research networks in 12 European countries 
included adult patients presenting with LRTI between October 2007 
and April 2010. All primary care research networks had access to a 
minimum of 20 000 patients.
Measurements
GPs recorded co morbidities (diabetes, respiratory and cardiovascu-
lar disease), body temperature and respiratory rate.
Patients responded to initial questions about the number of days 
they had felt ill before consultation and then answered questions 
about the severity of symptoms (cough, phlegm, shortness of breath, 
wheeze, blocked/runny nose, chest pain, fever, headache, disturbed 
sleep and feeling generally unwell) on a 7-point Likert-scale from 
0 (not affected) to 6 (as bad as it could be) each day for 28-days or 
until symptoms resolved in a self-complete diary. This part of the 
questionnaire was derived from a symptom diary used earlier and is 
internally reliable, valid and sensitive to change for acute LRTI (8). 
In addition, each week patients completed the EQ5D questionnaire 
items referring to feeling anxious or depressed, answering a 3-point 
Likert-scale (from no problem to extreme problem). Patients only 
recorded these items if they had relevant symptoms during the pre-
ceding week. Moreover, there were weekly questions about illness 
related behaviour represented by questions about over the counter 
medication (OTC) use, social activities, daily activities (responses 
on a 7 point Likert-scale), work/school absence and health seeking 
behaviour. Independent translators performed back translation of 
the diaries from local languages to English. Patients were telephoned 
4 days after inclusion with an offer of support in the sense that they 
were invited to ask questions on the diary if things were unclear, and 
research assistants explained the diary as much as possible.
European regions
European regions were defined in two ways:
1. Based on geographical location and economic status, with a cut-off 
value of US$ 35 000 per capita for gross domestic product (9,10). 
This resulted in a North-West region that included England, Bel-
gium (two networks), France, Germany, Sweden, The Netherlands 
and Wales and a South-East region that included Italy, Poland 
(three networks), Slovakia, Slovenia and Spain (two networks).
2. Based on whether the primary healthcare system had a gate-
keeping role or whether patients had direct access to specialists 
care (a direct access health system) (11,12). The former included 
England, Italy, Poland, Slovenia, Slovakia, Spain, The Nether-
lands and Wales, and the latter Belgium, France, Germany and 
Sweden.
Outcome measures
The illness course was expressed as duration and severity of symp-
toms. The total illness duration was calculated by summing the dura-
tion of illness prior to consultation plus duration of illness after GP 
consultation in days. Severity of symptoms was defined by a symp-
tom severity score derived by the sum of scores for the 11 symptoms 
reported in the patients’ diaries scaled from 0 to 100 as a percentage 
of the maximum possible score. Similarly, the impairment severity 
score was derived as score for impact on daily activities, calculated 
from the daily questions on interference with normal and social 
activities.
Analysis
All missing data, except for the responders versus non-responders 
comparison, were imputed. Single imputation of missing values was 
performed by logistic regression analysis using other available patient 
characteristics to impute missing results. The chi-square test was used 
to compare proportions between groups and the Mann-Whitney U 
or Kruskal Wallis tests were used to compare means in variables with 
non-normal distribution. We evaluated whether differences in out-
comes between countries and regions could be fully explained by dif-
ferences in patients’ age, smoking status and/or co morbidity using 
multivariable logistic regression. For daily symptoms this was per-
formed for day 1, 14 and 28 (shown in note of Fig. 1). Medians were 
used as the cut-off value for continuous variables.
Results
Patient characteristics at inclusion
Three thousand one hundred six patients were included of whom 
81% (n  = 2530) returned their symptom diary. Patients returning 
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their diary were older [median age 52 (range 18–92) versus 42 
(18–91)] and less frequently current smokers (27% versus 34%). 
Regarding clinical findings they more often had increased respira-
tory rate (≥20 per minute) and abnormal temperature (≤36 or ≥38) 
at inclusion. (Table 1)
Participants’ median age was 52  years, 40% (n  =  1017) were 
male, and 28% (n = 707) had co morbidities. Ten patients were hos-
pitalized for this illness episode during the 28 day follow up period.
Illness course, perception and related behaviour
Data are presented in Table 2. The mean duration of illness prior to 
GP consultation was 9 (SD 8) days. Sixty-two per cent (n = 1566) 
of the patients had used one or more OTC medication before 
consultation. At inclusion almost all patients suffered from acute 
cough [99% n  =  2516, 68% (n  =  1730) of the patients experi-
enced dyspnoea and 84% (n = 2118) of the patients felt generally 
unwell (data not presented)]. Seventy-three per cent (n = 1849) of 
the patients experienced impairment of normal or social activities 
for at least 7 days. The mean symptom severity score at day 1 was 
36 (SD 18) and 4 (SD 7) at day 28. The steepest decline in symp-
tom scores occurred during the first week (Fig. 1). After 4 weeks 
79% (n = 1991) of all patients felt recovered (Fig. 2). Patients not 
feeling recovered at day 28 mainly reported cough (73%, n = 395 
out of 539) and/or phlegm production (58%, n = 315 out of 539). 
Twenty-eight per cent (n = 702) of all patients reconsulted their GP 
for this LRTI episode. Patients were absent from work/school for a 
mean of 4 (SD 5) days. During the illness episode 27% (n = 691) of 
the patients reported feeling anxious or depressed on at least one 
occasion.
Differences between countries
Inclusion characteristics of patients differed between countries 
regarding age, co morbidity, smoking status, respiration rate and 
body temperature. Moreover, duration of feeling unwell before visit-
ing the GP and OTC medication use differed (Table 2). At day 1, 
the mean symptom severity score and the mean impairment severity 
score differed by country. These differences decreased during fol-
low up (Fig. 1). Regarding follow-up, the total illness duration, the 
percentage of patients reconsulting and the amount of days absence 
from work (range 2–8) differed per country and country remained 
independently associated with these outcomes after adjusting for 
age, co morbidity and smoking status.
Differences between regions: North-West versus 
South-East
Inclusion characteristics of patients in the North-West region dif-
fered from those in the South-East region regarding age, co morbid-
ity, smoking status and body temperature (Table 3).
Patients in the North-West region had higher impairment sever-
ity scores during all 28  days and higher symptom severity scores 
after the first week. The mean difference in impairment severity score 
and symptom severity score between the North-West region and the 
South-East region during 28 days was 4 (SD 1) and 1 (SD 1) point 
respectively (data not presented).
Regarding follow-up, the total illness duration, the percentage 
of patient reconsulting and the number of days absent from work 
differed per region, and region remained independently associated 
with these outcomes after adjusting for age, co morbidity and smok-
ing status.
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Figure 1. Symptom severity score and impairment severity score in the different countries. No significant differences after adjusting for age, co morbidity and 
smoking status for symptom severity score day 1, and for impairment severity score day 14.
Table 1. Characteristics of responders and non-responders to the diary recorded by GPs at inclusion
Responders (n = 2530) Non-responders(n = 576) P-value Missings % (n)
Age, median (IQR) 52 (25) 42 (29) 0.000 0 (0)
Male gender, % (n) 40.2 (1017) 39.8 (229) 0.851 0 (0)
Co morbidity, % (n) 28.0 (707) 26.1 (150) 0.380 0.2 (5)
Smoking, % (n) 26.8 (678) 33.6 (193) 0.001 0.1 (3)
Respiratory rate > 20 per minute % (n) 22.9 (568) 16.5 (91) 0.001 2.5 (78)
Body temperature ≤36 or ≥38, % (n) 20.2 (506) 15.9 (91) 0.019 1.0 (31)
Duration of illness prior to consultation in days, mean (SD) 9.4 (7.8) 10.4 (17.3) 0.561 1.8 (31)
IQR, interquartile range.
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Figure 2. Percentage of patients with any symptom, cough and percentage 
of patients feeling recovered.
Differences between health care systems: gate-
keeping versus direct access
Inclusion characteristic of patients in countries with a direct access 
health system differed from those in countries with a gate-keeping 
system regarding co morbidity and respiratory rate (Table 3).
Patients in countries with direct access health system had higher 
impairment severity scores over all 28  days and higher symptom 
severity scores after day 5.  The mean difference in impairment 
severity score and symptom severity score during 28 days between 
countries with direct access versus those who have not was 3 (SD 
1) points and 1 (SD 1) point, respectively (data not presented). After 
adjusting for age, co morbidities and smoking status, health care sys-
tem was no longer significantly associated with total illness duration 
and reconsultation rates.
Discussion
Summary of main results
The majority of patients presenting with LRTI in primary care expe-
rienced impairment of normal or social activities for at least 1 week 
and 28% re-consulted their GP at least once more during the 28 days 
follow-up of this study. More than one out of five patients did not 
feel fully recovered at the end of this 28 day period. Moreover, we 
found important differences in total illness duration and illness 
behaviour, including absence from work/school, between European 
countries and regions. Differences between patients in countries with 
a gate-keeping primary health system as compared to patients in a 
direct-access health system were generally small.
Strengths and limitations of the study
To our knowledge, this is the first study on differences at the coun-
try-setting level in illness perception, course and related behaviour in 
patients with LRTI. The strengths of our study include the large size 
of the study population representing contrasting European countries 
and the high rates of follow up. Moreover, the 28-day follow up in 
our study was longer than most previous studies, which followed 
patients for 3 weeks or less after their first consultation. Our broad 
eligibility criteria increase the generalizability of our findings to 
patients with LRTI seen in routine primary care. We also recognise 
several potential limitations of our study. First, the representativeness 
of the sample at country level is limited in some cases by small 
numbers recruited in some countries, suggesting possible selection 
bias. Patients were being managed by GPs who were participat-
ing in research, and their practices may not be typical of practices 
in their country as a whole. However this risk is mitigated by GP 
training in study methods and using standardised eligibility criteria. 
Moreover, an analysis of main results was done without France and 
Italy because few patients were recruited from these sites, causing 
no significant changes. Second, patient inclusion characteristics dif-
fered between countries, although logistic regression suggested that 
differences in outcomes were not solely explained by differences in 
inclusion characteristics. Moreover the severity of the disease may 
have influenced illness behaviour. Finally we did not analyse the 
effect of antibiotic prescription in this study. Earlier studies within 
the GRACE-project however found that antibiotic prescribing—the 
amount and type of antibiotic—had little to no clinically relevant 
impact on illness course (13,14,15).
Comparison with existing literature
Reconsultation rates during the same illness episode in our study 
(28%) are in line with findings of earlier studies (16–28%) (16,17). 
Differences in severity of symptoms and recovery rate by different 
networks in Europe was shown by Butler et  al. (14) in an earlier 
GRACE study. The majority of patients experienced impairment of 
normal or social activities during at least 1 week. This is in concord-
ance with the study of Moore et al. (18) which showed patients with 
LRTI experience moderate to extreme restriction in activities for a 
median 7 days.
It has been previously found that a liberal approach to sick 
certification by GPs results in higher levels sickness absence, and 
more so in Northern European countries compared to Southern 
European countries, being highest in the Netherlands, Germany and 
Belgium (19,20). Our finding that the number of days of sick leave 
was a slightly higher in South-East European countries compared 
to North-West European countries is therefore surprising. This 
discrepancy suggests that that LRTI may cause relevant symptoms 
which are only in part influenced by regulations regarding sickness 
certification.
To our knowledge, no previous study has compared patients’ 
LRTI consultation behaviour between European countries. The pre-
viously mentioned study of Melker de et al. (6) showed differences in 
days of being ill before presentation with acute tonsillitis.
Interpretation of the results
A difference in illness behaviour by patients recruited in different 
countries is perhaps the most interesting aspect of this study. These 
differences reflect (unmeasured) differences such as in culture, socio-
economic status and health beliefs rather than geographical location 
per se.
There were differences in symptom severity score per region and 
health system, but a difference of 1 point in a scale from 0–100 is 
unlikely to be clinically important. The small differences between 
the regions with different health systems could partly be explained 
by the nature of condition we studied. LRTI is a generally benign, 
self-limiting illness and few patients directly access secondary health-
care facilities, resulting in comparable effected populations between 
European countries. In some countries the health-system may theo-
retically be considered as gate keeping, but there might be a gap 
between policy and practice.
Although LRTI seldom leads to serious complications, patients 
with LRTI experience impairment in daily activities for a longer 
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period of time. Addressing this impairment explicitly in the context 
of country level may make patients feel more reassured and could 
adequately reduce unnecessary reconsultation.
Conclusion
Patients presenting with LRTI in primary care react differently to 
symptoms, with striking differences between European countries in 
illness behaviour such as number of days absent from work. This 
could be related to cultural and socio-economic differences. Type 
of health system does not seem to have an important effect on 
recovery related outcomes. The differences in illness perception and 
related behaviour between regions should be taken into account 
when developing international guidelines and patient information 
for LRTI.
Acknowledgments
We would like to thank the entire GRACE team, including Prof. Joanna Coast 
for their diligence, expertise and enthusiasm. We are indebted to all of the 
patients who consented to be part of GRACE, without whom this study would 
not have been possible. Finally special thanks to Ted van Essen for helpful 
comments. The work reported on in this publication has been financially sup-
ported through the European Science Foundation (ESF), in the framework of the 
Research Networking Programme TRACE (www.esf.org/trace).
Declaration
Funding: 6th Framework Program of the European Commission (Reference: 
LSHM-CT-2005–518226), Research Foundation Flanders (Belgium) 
(G·0274·08N). The funding sources were not involved in the design, conduct, 
analysis and interpretation of the data, nor in the writing and decision to sub-
mit the paper.
Ethical approval: All research sites obtained ethical and competent authority 
approval from their local organizations. Patients who fulfilled the inclusion 
criteria were given written and verbal information on the study and asked for 
informed consent.
Conflict of interest: none.
References
 1. Winchester CC, Macfarlane TV, Thomas M, Price D. Antibiotic prescrib-
ing and outcomes of lower respiratory tract infection in UK primary care. 
Chest 2009; 135: 1163–72.
 2. Van der linden M, Westert G, de Bakker D, Schellevis F. Tweede nationale 
studie naar ziekten en verrichtingen in de huisartspraktijk. Utrecht, Bil-
thoven: NIVEL/RIVM 2004.
 3. Hopstaken RM, Coenen S, Butler CC et al. Prognostic factors and clinical 
outcome in acute lower respiratory tract infections: a prospective study in 
general practice. Fam Pract 2006; 23: 512–9.
 4. Verheij T, Hermans J, Kaptein A, Mulder J. Acute bronchitis: course of 
symptoms and restrictions in patients’ daily activities. Scand J Prim Health 
Care 1995; 13: 8–12.
 5. Leoni T, Biffl G, Guger A. Fehlzeitenreport 2007 - Krankheits- und unfall-
bedingte. WIFO 2008.
 6. de Melker RA, Touw-Otten FW, Kuyvenhoven MM. Transcultural differ-
ences in illness behaviour and clinical outcome: an underestimated aspect 
of general practice? Fam Pract 1997; 14: 472–7.
 7. van Vugt SF, Broekhuizen BD, Lammens C et al. Use of serum C reactive 
protein and procalcitonin concentrations in addition to symptoms and 
signs to predict pneumonia in patients presenting to primary care with 
acute cough: diagnostic study. BMJ 2013; 346: f2450.
 8. Watson L, Little P, Moore M, Warner G, Williamson I. Validation study of 
a diary for use in acute lower respiratory tract infection. Fam Pract 2001; 
18: 553–4.
 9. Composition of macro geographical (continental) regions, geographical sub-
regions, and selected economic and other groupings. 2011. http://unstats.
un.org/unsd/methods/m49/m49regin.htm (accessed on August 1, 2012).
 10. Per Capita GDP in US Dollars. United Nations Stat. Div. 2011. http://
unstats.un.org/unsd/snaama/Introduction.asp (accessed August 1, 2012).
 11. European observatory on health systems and policies. WHO. 2012. http://
www.euro.who.int/en/who-we-are/partners/observatory/health-systems-
in-transition-hit-series/hit-summaries (accessed on August 1, 2012).
 12. Bíró A. Copayments, gatekeeping, and the utilization of outpatient 
public and private care at age 50 and above in Europe. Health Policy 
2013;111:24–33.
 13. Brookes-Howell L, Hood K, Cooper L et al. Clinical influences on anti-
biotic prescribing decisions for lower respiratory tract infection: a nine 
country qualitative study of variation in care. BMJ Open 2012;2:1–7.
 14. Butler CC, Hood K, Verheij T et  al. Variation in antibiotic prescribing 
and its impact on recovery in patients with acute cough in primary care: 
prospective study in 13 countries. BMJ 2009; 338: b2242.
 15. Little P, Stuart B, Moore M et  al. Amoxicillin for acute lower-respira-
tory-tract infection in primary care when pneumonia is not suspected: a 
12-country, randomised, placebo-controlled trial. Lancet Infect Dis 2013; 
13: 123–9.
 16. Macfarlane J, Prewett J, Rose D et al. Prospective case-control study of role 
of infection in patients who reconsult after initial antibiotic treatment for 
lower respiratory tract infection in primary care. BMJ 1997; 315: 1206–10.
 17. Holmes WF, Macfarlane JT, Macfarlane RM, Hubbard R. Symptoms, 
signs, and prescribing for acute lower respiratory tract illness. Br J Gen 
Pract 2001; 51: 177–81.
 18. Moore M, Little P, Rumsby K et al. Predicting the duration of symptoms 
in lower respiratory tract infection. Br J Gen Pract 2008; 58: 88–92.
 19. Osterkamp R, Rohn O. Being on Sick Leave: Possible Explanations for 
Differences of Sick-leave Days Across Countries. CESifo Econ Stud 2007; 
53: 97–114. http://cesifo.oxfordjournals.org/cgi/doi/10.1093/cesifo/
ifm005 (accessed September 27, 2014).
 20. Gimeno D, Benavides FG, Benach J, Amick BC. Distribution of sickness 
absence in the European Union countries. Occup Environ Med 2004; 61: 
867–9. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=17406
73&tool=pmcentrez&rendertype=abstract (accessed September 27, 2014).
D
ow
nloaded from
 https://academ
ic.oup.com
/fam
pra/article-abstract/32/2/152/534116 by guest on 10 June 2020
